Search - tctmd.com

Displaying 21 - 40 of 1188

Sort: Relevancy | Date

Presentation TCT 2025

Alternate Routes of Administering Diuretics that Bypass the Gut

Presenter: Andrew Ambrosy

October 28, 2025

Presentation TCT 2025

Congestion in Heart Failure: Limitations of Diuretic Therapies and the Need for Device-Based Approaches

Presenter: Daniel Burkhoff

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Personalizing Heart Failure Therapy With Non-Invasive Cardiac & Pulmonary Pressure Sensing (Acorai)

Presenter: Filip Peters

October 27, 2025

Presentation TCT 2025

TCT 548: HEalth economics for Advanced heaRT failure and Mechanical Circulatory Support: the HEART-MCS group

Presenter: Elina Eleftheria Pliakos

October 27, 2025

Presentation TCT 2025

TCT 273: Outcomes with Impella CP in Acute Myocardial Infarction versus Heart Failure Cardiogenic Shock: Insights from the Cardiogenic Shock Working Group

Presenter: Michele Esposito

October 27, 2025

Presentation TCT 2025

TCT 545: Pressure-Volume Loop Evaluation Supporting the Hemodynamic Performance of the Percutaneous Synchronized Cardiac Assist (PSCA) System

Presenter: Daniel Burkhoff

October 27, 2025

Presentation TCT 2025

TCT 546: Real-World Clinical Outcomes Using Bicarbonate Purge Solution during Impella 5.5 Support: A Data Linkage Analysis

Presenter: Ahmad Zeeshan

October 27, 2025

Presentation TCT 2025

TCT 544: A Hybrid Deep Learning Model For Automated Detection and Classification of Cardiomyopathies Using Cardiac Magnetic Resonance Images

Presenter: Saman Al Barznji

October 27, 2025

Presentation TCT 2025

TCT 542: Trends in Postpartum Cardiomyopathy Mortality in the United States (2018–2023): Insights from the CDC WONDER Database

Presenter: Samra Iqbal

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

TCT 1345: A Shell of a Man: Percutaneous Transcatheter Mitral Valve in Valve Replacement in Heart Failure With Multi-Organ Failure

Presenter: Jonathan Schilling

October 27, 2025

Presentation TCT 2025

TCT 1916: Successful Percutaneous Transluminal Renal Angioplasty for Atherosclerotic Bilateral Renal Artery Stenosis in a Super-Elderly Patient With Refractory Hypertension, Acute Heart Failure, and Renal Failure

Presenter: Kota Komiyama

October 27, 2025

Presentation TCT 2025

TCT 298: Black Race Associated With Higher Mortality and Heart Failure After CABG: A Real-World Matched Cohort Study

Presenter: Ronak Bharucha

October 27, 2025

Presentation TCT 2025

TCT 395: Lactate/Albumin and RDW/Albumin Ratios for Mortality and Readmission in Post-Myocardial Infarction Heart Failure

Presenter: Amogh Killedar

October 27, 2025

Presentation TCT 2025

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

Presenter: Hasan Munshi

October 27, 2025

Presentation TCT 2025

TCT 539: Peripartum Cardiomyopathy in Italy: Can Severe Cases Recover Without Mechanical Support? Insights from a National Registry

Presenter: Marco Licciardi

October 27, 2025

Presentation TCT 2025

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

Presenter: Kari A. Saville

October 27, 2025

Advertisement

Alternate Routes of Administering Diuretics that Bypass the Gut

Congestion in Heart Failure: Limitations of Diuretic Therapies and the Need for Device-Based Approaches

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Personalizing Heart Failure Therapy With Non-Invasive Cardiac & Pulmonary Pressure Sensing (Acorai)

TCT 548: HEalth economics for Advanced heaRT failure and Mechanical Circulatory Support: the HEART-MCS group

TCT 273: Outcomes with Impella CP in Acute Myocardial Infarction versus Heart Failure Cardiogenic Shock: Insights from the Cardiogenic Shock Working Group

TCT 545: Pressure-Volume Loop Evaluation Supporting the Hemodynamic Performance of the Percutaneous Synchronized Cardiac Assist (PSCA) System

TCT 546: Real-World Clinical Outcomes Using Bicarbonate Purge Solution during Impella 5.5 Support: A Data Linkage Analysis

TCT 544: A Hybrid Deep Learning Model For Automated Detection and Classification of Cardiomyopathies Using Cardiac Magnetic Resonance Images

TCT 542: Trends in Postpartum Cardiomyopathy Mortality in the United States (2018–2023): Insights from the CDC WONDER Database

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

TCT 1345: A Shell of a Man: Percutaneous Transcatheter Mitral Valve in Valve Replacement in Heart Failure With Multi-Organ Failure

TCT 1916: Successful Percutaneous Transluminal Renal Angioplasty for Atherosclerotic Bilateral Renal Artery Stenosis in a Super-Elderly Patient With Refractory Hypertension, Acute Heart Failure, and Renal Failure

TCT 298: Black Race Associated With Higher Mortality and Heart Failure After CABG: A Real-World Matched Cohort Study

TCT 395: Lactate/Albumin and RDW/Albumin Ratios for Mortality and Readmission in Post-Myocardial Infarction Heart Failure

TCT 762: Impact of Preoperative Beta-Blockade on Outcomes in Heart Failure Patients Undergoing Surgical Aortic Valve Replacement

TCT 539: Peripartum Cardiomyopathy in Italy: Can Severe Cases Recover Without Mechanical Support? Insights from a National Registry

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content